When should pharmacologic therapy be considered for hypertriglyceridemia (high triglyceride levels)?

Updated: Jul 23, 2021
  • Author: Mary Ellen T Sweeney, MD; Chief Editor: Romesh Khardori, MD, PhD, FACP  more...
  • Print

Consider pharmacologic therapy if the LDL-C level remains above the following thresholds [51] :

  • Patients with low risk, 190 mg/dL or greater

  • Patients with moderate risk, 160 mg/dL or greater

  • Patients with moderately high risk, 130 mg/dL (option 100 mg/dL) or greater

  • Patients with high risk, 100 mg/dL (option 70 mg/dL) or greater

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!